KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Dynavax Technologies (DVAX) Debt to Equity: 2009-2021

Historic Debt to Equity for Dynavax Technologies (DVAX) over the last 3 years, with Mar 2021 value amounting to $1.80.

  • Dynavax Technologies' Debt to Equity fell 88.13% to $1.80 in Q1 2021 from the same period last year, while for Mar 2021 it was $7.21, marking a year-over-year decrease of 88.04%. This contributed to the annual value of $3.06 for FY2020, which is 85.78% down from last year.
  • Dynavax Technologies' Debt to Equity amounted to $1.80 in Q1 2021, which was down 41.14% from $3.06 recorded in Q4 2020.
  • Over the past 5 years, Dynavax Technologies' Debt to Equity peaked at $21.54 during Q4 2019, and registered a low of $0.60 during Q1 2018.
  • For the 3-year period, Dynavax Technologies' Debt to Equity averaged around $8.06, with its median value being $4.07 (2019).
  • Its Debt to Equity has fluctuated over the past 5 years, first spiked by 2,095.68% in 2019, then slumped by 88.13% in 2021.
  • Dynavax Technologies' Debt to Equity (Quarterly) stood at $1.60 in 2018, then surged by 1,246.95% to $21.54 in 2019, then crashed by 85.78% to $3.06 in 2020, then tumbled by 88.13% to $1.80 in 2021.
  • Its Debt to Equity was $1.80 in Q1 2021, compared to $3.06 in Q4 2020 and $2.59 in Q3 2020.